Cas-CLOVER: The Clean Alternative to CRISPR-Cas9

In this GEN webinar, sponsored by Hera BioLabs, we will hear from scientific experts about the design and implementation considerations for Cas-CLOVER, as well as validation data for the use of this gene-editing system in human and CHO cells, as well as yeast and plants.
Big Genomic Data

Settling the Score with Genetic Diseases

In this GEN Keynote Webinar, Sekar Kathiresan, MD, Co-Founder & CEO of Verve Therapeutics and renowned physician-scientist who has produced major advances on the development and deployment of polygenic risk scores (PRSs), will discuss advances in our understanding of complex genetic diseases and the current state of development and validation for PRSs. Kathiresan will also discuss the potential for these scores to improve clinical care.

Recently Featured

Scroll Up